Skip to main content
. 2016 Jun;13(2):248–259. doi: 10.20892/j.issn.2095-3941.2016.0023

Figure4.

Figure4

Therapeutic targets in BM niche. Cytokines, chemokines, and the extracellular matrix activate the pro-survival signaling pathways, such as PI3K/Akt, MAPK, STAT3, and NF-кB, which regulate downstream components likely promoting survival and proliferation of LSCs. The therapeutic strategies designed to overcome stroma-mediated chemoresistance and target the LSC include adhesion molecule and cytokine antagonists as well as inhibitors of intracellular pro-survival and self-renewal pathways.